Eagle Bancorp Montana Earns $4.7 Million, or $0.60 per Diluted Share, for the Fourth Quarter of 2025, and $14.8 Million, or $1.90 per Diluted Share, for the Year 2025; Declares Quarterly Cash Dividend of $0.145 Per Share HELENA, Mont., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Eagle Bancorp Montana, Inc. (NASDAQ: EBMT), (the “Company,” “Eagle”), the holding company of Opportunity Bank of Montana (the “Bank”), today reported net income increased 30.3% to $4.7 million, or $0.60 per diluted share, in the fourth quarter of 2025, compared to $3.6 million, or $0.46 per diluted share, in the preceding q...
Luxury Meets Logistics: Quadient Launches PREMIER Locker for Upscale Multifamily Communities Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, announces its new Parcel Pending by Quadient , the first of its kind package locker designed for upscale multifamily living and package deliveries. The PREMIER Locker’s sleek, modern aesthetic is designed for luxury multifamily communities looking to differentiate themselves with high-end amenities. The PREMIER Locker’s 15.6-inch HD portrait color touchscreen provides a crisp, intuitiv...
A director at Tianli International Holdings Limited bought 900,000 shares at 2.723HKD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...
A director at Zad Holding Co bought 18,118 shares at 0.000QAR and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
A director at Darden Restaurants Inc sold 3,123 shares at 205.319USD and the significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
A director at PT Archi Indonesia Tbk sold 13,190,800 shares at 2,030.000IDR and the significance rating of the trade was 84/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Honda’s Auto operations are under pressure, as extraordinary factors, as well as fundamental company-specific issues, are weighing on profits. Auto sales have fallen substantially over the last two years as Honda is struggling with its market positioning and product line-up. Analyst Julie Boote notes that business risks in both the Auto and the (currently successful) Motorcycle division suggest that a longer lasting recovery following the write-off year FY25 might not be on the cards.
A director at Qatar Islamic Bank sold 161,653 shares at 0.000QAR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™ Alpha selected as the first Medspa platform partner given their commitment to innovation, education, and breaking through barriers NEW YORK and SACRAMENTO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced that it has partnered with Alpha Aesthetic Partners for...
Special Opportunities Fund Announces Results of Year-End Distribution Payable in Cash and Stock NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Special Opportunities Fund, Inc. (NYSE: SPE) (the “Fund”) today announced that the price at which shares of the Fund’s common stock will be issued to common stockholders of record as of December 29, 2025 and payable on January 30, 2026 is $14.9506 which is the volume-weighted average trading price of the Fund’s common stock on January 20, 21, and 22, 2026. Substantially the entire $0.70 per share distribution is expected to consist of realized long-t...
With the CHTR/Cox deal moving towards approval and CMCSA out of running for WBD, we are again getting questions as to whether CMCSA could buy the combined CHTR/Cox entity. Further, as our New Street colleagues discussed yesterday, there has been a divergence in the stock price performances of Comcast and Charter driven by a potential ‘value unlock’ resulting from a potential split of Comcast cable from NBCU. It is beyond the scope of our expertise to analyze the financial details that could jus...
Boralex will release its 2025 fourth quarter financial results on February 27, at 11 a.m. MONTREAL, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) announces that the release of the 2025 fourth quarter results will take place on Friday, February 27, 2026, at 11 a.m. Financial analysts and investors are invited to attend a conference call during which the financial results will be presented. Date and time Friday, February 27, 2026, at 11 a.m. ET To attend the conference Webcast link: To attend the event by phone: to register for the ea...
Boralex dévoilera ses résultats financiers du 4e trimestre de l’exercice financier 2025 le 27 février, à 11 h MONTRÉAL, 27 janv. 2026 (GLOBE NEWSWIRE) -- Boralex inc. (« Boralex » ou la « Société ») (TSX : BLX) annonce que la divulgation des résultats financiers du quatrième trimestre de l’exercice financier 2025 aura lieu le vendredi, 27 février 2026, à 11 h. Les analystes financiers et investisseurs sont invités à assister à une conférence téléphonique au cours de laquelle ces résultats seront présentés. Date et heure Vendredi, 27 février 2026, à 11 h (HE) Pour assister à la confére...
A director at Lee Swee Kiat Group Berhad bought 9,230,000 shares at 0.380MYR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
Frequency Electronics Inc. Announces a contract award valued at approximately $6.0 million MITCHEL FIELD, N.Y., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM), a leading provider of precision timing and frequency control products for space and terrestrial applications, is pleased to announce the follow-on award of several contracts from a major aerospace company for precision “g” (acceleration) compensated Oven-controlled Quartz Oscillators (OCXO) for ultimate application in US Government software-defined radio systems. These precision...
INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives Boca Raton, FL, Jan. 27, 2026 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, presents the following letter to investors from David Moss, CEO: Dear Fellow Shareholders, As we reflect on 2025, I want to thank you for your continued support of INmune Bio. This past year marked an important period of execution, discipline, and focus as we advanced our mission to develop innovative therapies that address serious neuroinflamma...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.